Role of irbesartan in prevention of post-coronary artery bypass graft atrial fibrillation. [electronic resource]
Producer: 20111027Description: 277-84 p. digitalISSN:- 1179-187X
- Age Factors
- Angiotensin II Type 1 Receptor Blockers -- therapeutic use
- Atrial Fibrillation -- etiology
- Biphenyl Compounds -- therapeutic use
- Coronary Artery Bypass -- adverse effects
- Female
- Humans
- Irbesartan
- Logistic Models
- Male
- Middle Aged
- Pilot Projects
- Postoperative Complications -- prevention & control
- Prospective Studies
- Single-Blind Method
- Tetrazoles -- therapeutic use
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.